Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
More like a bunker-buster. Lol.
Wasn’t it Pestell that said this is essentially “de-risked” and that we are “on the one-yard line about to score”? And now he’s been fired...for cause.... so many questions.
Common sense. Love it.
Appreciate the warning. You have basically summed up what it’s like to invest in literally ANY pre-FDA approval drug and company that is also pre-revenue. Nothing surprising here.
And, not to get hung up on technicalities here, but RP did not “depart” the company, he was fired. Big difference. Not happy about it, but maybe I will be if I find out why he was fired. Time will tell....
Best of luck Bucky
It’s a very clear pattern....CYDY comes out with positive news, or an announcement of new developments coming, and she shows up, with a shotgun blast of manipulating fury.
It’s comical and beyond boring at this point.
Thanks Grip, we’ve been here a long time. Patience will win the day here, best of luck to you.
That’s right, now I remember. I wasn’t inferring they had a “fight”. I thought I quoted you properly but didn’t look up your actual post, so for what it’s worth.
I have no doubt they have their moments of disagreement when so much is at stake and they are two strong personalities who are used to being the leaders of their own respective projects.
Well enough about this, onward to a positive and informative CC next week. Thanks for your input, always appreciated.
I remember back from one of the recent investor conferences in Portland, someone mentioned that they saw Nader and RP having a “heated exchange” just before the meeting. Could have been over breakfast menu, or something a little more serious. I also have been concerned that he’s gone radio silent. Hoping for some clarity next week.
So go invest in GILD and be done here. See? Problem solved.
It’s just another manic-Monday....
Wait let me get my popcorn before you elaborate on “what that indicates”.....
Pestell has been quiet lately......hasn't gone unnoticed.
The shorts came in and destroyed it
And on that note, did anyone see the news on the “disappearance” of “prominent AIDS researcher” Dr Charles Van Der Horst recently? He disappeared during a swimming event on the Hudson River last week.
https://www.newsobserver.com/news/local/article231598783.html
Same here. One thing is for sure, if I ever want to get a real good dose of rain on my parade all I have to do is read this iHub board and voila!
Amen.
I’m going to assume you ran this by the company to get it going, right?
Let us know what they said. Thanks.
Got it. Haha. True. Let’s get this show on the road.
TO closes 6/12...maybe (dare I say hopefully) things will heat up after that....
I think what you meant was subcutaneously injected but never intravenously injected.... still injected, but big difference.
Touché
Thanks, Captain Obvious!
Yeah taking a serious beating. Get the defibrillator.
Hmmmm.... still waiting for that.
Good points. I thought it was interesting considering everything we discuss here concerning Gilead.
Did you all see the announcement today of the deal the Trump administration has made with Gilead for donated HIV drugs for the next 11 years for 200,000 patients in the USA?
FYI: “emotion-based” and speculative investing in an FDA trial biotech are NOT compatible.
Not opinion, fact.
Agreed. Won't be the drastic move we saw on the other stock due to it being a low-float...But I'd rather see a steady upward move with stacked good catalysts here for sure....Thanks for the input.
Day traders..... and they will, when the time is right... and buckle up 'cause it's going to be one heck of a ride. We just need the right catalyst here....
Talk about a massive short-squeeze!
Our BPTH moment is coming...
Ah, you're correct, I was thinking nasdaq. Well, let's see it get there either way. Thanks for your responses.
I would love for it not to happen, but unless there is something coming up in the next 60 days to bump the stock price back over $1.00, they are out of time according to the latest deadline. What do you see happening here?
Except for that pesky R/S that is looming large.... Ugh....
They need to do better than this, April 30 is fast approaching!
This is just speculation, but maybe, possibly, they were advised to dissociate publicly with Charlie...he’s not exactly the guy you really want as the poster child for your potentially world-changing platform drug....
Excellent questions for Monday’s CC.
I think you're confusing side effects with effectiveness. If a drug is going to cause side effects, it will cause those side effects irregardless of what disease you are treating typically, and it is commonly dose dependent. To your assumed question, is Leronlimab going to be as effective at halting cancer metastasis (in humans) as it is at decreasing HIV viral load in humans, we will soon find out. We already know Leronlimab is safe.
Thanks Chump.
Chump can you please re-sticky Trding’s corrected version? “Monotherapy”. Thanks!
Haha no doubt. Nice work!